Continuing Education, Conferences, ...
Professor Petrides is actively involved in continuing education and professional exchange at the national and international level. Whether as an organizer of DFG-funded conferences, a speaker at international congresses or a member of renowned professional societies, his work has had a significant impact on the development of hematology and oncology.
Continuing Education
In-House Continuing Education Courses Certified by the BLÄK
- Current Aspects of the Diagnosis and Treatment of Iron Deficiency
- Adjuvant Therapy of Breast Cancer
- Breast Cancer for Physicians with an Interest in Oncology
- Shared Care of Cancer Patients by General Practitioners, Oncologists and Radiation Oncologists
- New Developments in the Diagnosis and Treatment of Colorectal Cancer
- Lectures at Ludwig-Maximilians-Universität München (uni-muenchen.de)
- Molecular and Clinical Aspects of Iron Metabolism / Chronic Myeloproliferative Disorders, Acute and Chronic Porphyrias.
Conferences
International DFG Conferences,
Fraueninsel, Chiemsee
- "The multigene family of Peroxidases": Biochemical Basis and Clinical Applications:
September 27 to October 2, 1998 – together with William Nauseef, Iowa City University, USA - Towards an Understanding of the Molecular Basis of Myeloproliferative Disorders:
September 23 to 28, 2000 – together with Heike Paal, University of Freiburg, Breisgau - Molecular and Clinical Aspects of human Iron Metabolism:
September 28 to October 3, 2002 – together with Ernest Beutler, Scripps Institute of Molecular Medicine, La Jolla, California, USA. - Mechanism of Thrombus Formation:
September 24 to 29, 2005 – together with Bruce Furie, Harvard University Boston, USA - Tissue Fibrogenesis: From biochemical Analysis to targeted Therapies:
September 25 to 30, 2010 – together with David Brenner, University of California, San Diego, USA
All conferences with the support of the Deutsche Forschungsgemeinschaft (German Research Foundation, dfg.de)
Proceedings with all lectures have been published for the 2000 and 2004 conferences:
- Petrides PE, Nauseef W: The multigene Family of Peroxidases, Springer Verlag, Heidelberg / New York, 2000
- Petrides PE, Paal H: Molecular Basis of Myeloproliferative Disorders, Springer Verlag Heidelberg / New York, 2004
The complete lectures of the 2002, 2005 and 2010 conferences were published in international journals.
Memberships
Membership in National and International Professional Societies
- AIO – Arbeitsgemeinschaft Internistische Onkologie (Working Group Medical Oncology), aio.de
- ASCO – American Society of Clinical Oncology, asco.org
- ASH – American Society of Hematology, hematology.org
- ÄKBV – Ärztlicher Kreisverband München (Munich District Medical Association), aekbv.de
- BDI – Berufsverband Deutscher Internisten (Professional Association of German Internists), bdi.de
- BLÄK – Bayerische Landesärztekammer (Bavarian State Medical Association), blaek.de
- BNHO – Berufsverband niedergelassener Hämato-Onkologen (Professional Association of Office-Based Hematologists and Oncologists), bnho.de
- CEMPO – Central European Myeloproliferative Neoplasm Organisation, cempo.org
- DGHO – Deutsche Gesellschaft für Hämato- und Onkologie (German Society of Hematology and Oncology), dgho.de
- DKG - Deutsche Krebsgesellschaft (German Cancer Society), dkg.de
- DSS - Deutsche Gesellschaft für Senologie (German Society of Senology, breast diseases), senologie.org
- ESMO – European Society of Medical Oncology, esmo.org
- EHA – European Hematological Association, eha.org
- NOGGO – Nord-Ost-Gesellschaft für Gynäkologische Onkologie (North-East German Society of Gynecological Oncology), noggo.de)
- Süddeutsche Hämoblastose-Gruppe (South German Hemoblastosis Group)
- Leukämie-Netzwerk (Leukemia Network), kompetenznetz-leukaemie.de
Doctoral Theses
Supervision of Doctoral Theses
- Olivia Bronisch: Akute Porphyrien – eine monozentrische Langzeitanalyse der biochemischen, molekulargenetischen und klinischen Daten von 62 Betroffenen, 2019, Dr. med. Current position: Department of Internal Medicine, University Hospital Gießen
- Fabian Siegel: Untersuchungen zur Symptomatik und Therapie chronisch myeloproliferativer Erkrankungen (Polycythaemia vera und primäre Thrombozythämie), 2015, Dr. med. Current position: specialist in urology, Department of Urology, University Hospital Mannheim
- Jan Tauscher: Untersuchungen zur Thromboseentstehung bei Patienten mit chronisch myeloproliferativen Neoplasien, 2012, Dr. med. Current position: general medicine practice, Oberstdorf, Bavaria
- Leon von Brasch: Molekularbiologische Untersuchungen bei Patienten mit akut intermittierender Porphyrie, 2006, Dr. med. Current position: Managing Commercial Director, Schön Klinik Lübeck
- Chuanbing Zang: Invasive behaviour of the promyelocytic leukemia cell line NB4 before and after treatment with differentiation inducers, 2003, Dr. hum. biol. Current position: research associate, Department of Hematology/Oncology, Charité, Humboldt University Berlin
- Manfred Ismair: Molekularbiologische Untersuchungen zur Rolle und Regulation der Matrixmetalloproteinase 9 und ihres Inhibitors bei der Promyelozyten-Leukämie-Zelllinie NB4, 2000, Dr. rer. nat. Current position: Chief Executive Officer (CEO), Xenogesis, Nottingham, England
- Florian Loher: Bildung von Typ IV-Kollagenasen durch mononukleäre Knochenmarkzellen von Patienten mit myeloischen Leukämien oder myelodysplastischen Syndromen, 1999, Dr. med., Dipl.-Pharm. Current position: European Patent Office, Munich
- Oliver M. Trapp: Anagrelide: ein neuer Wirkstoff zur Behandlung primärer Thrombozythämien, 1999, Dr. med. Current position: chief physician, Trauma Center Murnau, Bavaria
- Philipp le Coutre: Untersuchungen zur Ausscheidung von EGF (Epidermal Growth Factor) in den Urin von Patienten mit Nierenzellkarzinom und Gesunden, 1995, Dr. med. Current position: Prof. Dr. med., senior physician, Department of Hematology and Oncology, Charité, Humboldt University Berlin
- Christian Ries: Reinigung, biochemische Charakterisierung und Regulation der Sekretion von Typ IV-Collagenasen/Gelatinasen bei der Leukämiezelle HL-60, 1994, Dr. rer. nat. Current position: Prof. Dr. rer. nat., Institute of Epidemiology of Cardiovascular Diseases, LMU Munich
- Klaus Dittmann: In vitro-Wechselwirkungen zwischen Leukämie- und Knochenmarksstromazellen: Charakterisierung und Identifizierung einer neuen Metalloprotease, 1991, Dr. rer. nat. Current position: Prof. Dr. rer. nat., Institute of Radiation Biology, University of Tübingen
- Susanne Bock: Untersuchung zur Pro-EGF (Epidermal Growth Factor) und EGF-Rezeptorexpression bei gesunden Nieren und Nierenzellkarzinom des Menschen, 1991, Dr. hum. biol. Current position: Ulm
Examinations
Successfully Completed Examinations
ESMO examinations 2005 and 2011
(voluntary examinations covering the entire field of oncology as a knowledge check, esmo.org)
Examiner Activities
BLÄK (Bavarian State Medical Association): hematology and oncology, drug-based tumor therapy; state examination, LMU Munich